Fincoid--a new copper IUD: a preliminary report

Area of Science:

• Reproductive Health
• Contraception
• Gynecology

Background:

• Intrauterine devices (IUDs) are a common form of reversible contraception.
• Previous IUD use, particularly copper IUDs, is often discontinued due to side effects.
• Evaluating novel IUDs is crucial for expanding contraceptive options.

Purpose of the Study:

• To assess the safety and efficacy of the new Fincoid copper intrauterine device (IUD).
• To evaluate continuation rates and reasons for discontinuation in a diverse patient population.
• To compare outcomes between nulliparous and parous women using the Fincoid IUD.

Main Methods:

• A preliminary study involving 956 first-time insertions of the Fincoid copper IUD.
• 10,015 woman-months of follow-up, with individual follow-up extending to 12 months.
• Data collected on pregnancy, expulsion, removal for side effects, and infection rates, stratified by parity.

Main Results:

• The net cumulative rates at 12 months were: pregnancy 1.1%, expulsion 4.7%, removal for bleeding/pain 7.6%, and infection 0.8%.
• The overall continuation rate was 78.9%, with a 2.8% loss to follow-up.
• Nulliparous women experienced higher rates of pregnancy, expulsion, and infection compared to parous women.

Conclusions:

• The Fincoid copper IUD demonstrates a valid performance profile for intrauterine contraception.
• The device appears safe and effective, with acceptable continuation rates.
• Parity influences IUD outcomes, with nulliparous women requiring closer monitoring for adverse events.